Objective: Modulating effects of genetic and environmental risk factors on severity of human abdominal aortic aneurysm (AAA) tissue inflammation remain unclear. We investigated the influence of total plasma homocysteine (tHcy) and traditional atherosclerotic risk factors (ARF) on degree of AAA tissue inflammation. Methods: Aneurysm specimens were obtained from 89 male patients aged 52 to 83 years, underwent asymptomatic not ruptured AAA (mean diameter 5.5 cm) open repair and graded for degree of histologic inflammation. Multivariate analysis was used to determine the association of tHcy and ARF, with degree of inflammation. Results: Current cigarette smoking, odds ratio (OR) 4.4, 95% confidence interval 1.3 to 15.2, P = .01 and no other ARF, neither tHcy levels OR 0.9 (0.9-1.02), P = .2 were associated with high-grade tissue inflammation. Conclusion: These results provide evidence against a major effect of tHcy levels on AAA tissue inflammation, while current cigarette smoking is a significant modulating factor.
McCormick ML , Gavrila D., Weintraub NLRole of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol . 2007;27(3):461-469.
4.
Michel JB, Thaunat O., Houard X., Meilhac O., Caligiuri G., Nicoletti A.Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler Thromb Vasc Biol. 2007;27(6):1259-1268.
5.
Boers GHMild hyperhomocysteinemia is an independent risk factor of arterial vascular disease. Semin Thromb Hemost. 2000 ;26(3):291-295.
6.
Brunelli T. , Prisco D., Fedi S., Rogolino A., Farsi A., Pepe G.High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vasc Surg. 2000;32(3):531-536.
7.
Caldwell S. , Sykes T., Mosquera D.Regarding ‘‘High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. ’’ J Vasc Surg . 2002;35(2):408.
8.
Spark J., Laws P., Fitridge R.The incidence of hyperhomocysteinaemia in vascular patients. Eur J Vasc Endovasc Surg. 2003;26(5):558-561.
9.
Warsi A., Davies B., Morris-Stiff G., Hullin D., Lewis M.Abdominal aortic aneurysm and its correlation to plasma homocysteine, and vitamins. Eur J Vasc Endovasc Surg. 2004 ;27(1):75-79.
10.
Maiellaro K. , Taylor WRThe role of the adventitia in vascular inflammation . Cardiovasc Res. 2007;75(4):640-648.
11.
Moroz P., Le MTQ, Norman PEHomocysteine and abdominal aortic aneurysms. ANZ J Surg. 2007;77(5): 329-332.
12.
Chambers JC , Ueland PM, Obeid OA, Wrigley J., Refsum H., Kooner JSImproved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation. 2000;102(20):2479-2483.
13.
Riba R., Nicolaou A., Troxler M., Homer-Vaniasinkam S., Naseem K.Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels. Atherosclerosis . 2004;175(1):69-75.
Rasmussen TE , Hallett JW, Tazelaar HD, et al. Human leukocyte antigen class II immune response genes, female gender, and cigarette smoking as risk and modulating factors in abdominal aortic aneurysm. J Vasc Surg. 2002;35(5):988-993.
16.
Rohde LEP , Arroyo LH, Rifai N., et al. Plasma concentrations of interleukin-6 and abdominal aortic diameter among subjects without aortic dilatation. Arterioscler Thromb Vasc Biol. 1999;19(7):1695-1699.
17.
Sofi F., Marcucci R., Giusti B., et al. High levels of homocysteine, lipoprotein (a) and plasminogen activator inhibitor-1 are present in patients with abdominal aortic aneurysm . Thromb Haemost. 2005;94(5):1094-1098.
18.
Strauss E., Waliszewski K., Garbriel M., Zapalski S., Pawlak A.Increased risk of the abdominal aortic aneurysm in carriers of the MTHFR 677T allele. J Appl Genet. 2003;44(1):85-93.
19.
Jones G., Harris E., Phillips L., van Rij A.The methylenetetrahydrofolate reductase C677T polymorphism does not associate with susceptibility to abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2005;30(2):137-142.
20.
Peeters AC, van Aken BE, Blom HJ, Reitsma PH, den Heijer M.The effect of homocysteine reduction by B-vitamin supplementation on inflammatory markers. Clin Chem Lab Med. 2007;45(1):54-58.
21.
Schernthaner GH, Plank C., Minar E., Bieglmayer C., Koppensteiner R., Schernthaner G.No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease. Eur J Clin Invest . 2006;36(5):333-339.
22.
Bleie Ø , Semb AG, Grundt H., et al. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. J Intern Med. 2007 ;262(2):244-253.
23.
Charpiot P. , Bescond A., Augier T., et al. Hyperhomocysteinemia induces elastolysis in minipig arteries: structural consequences, arterial site specificity and effect of captopril-hydrochlorothiazide. Matrix Biol. 1998;17(8-9): 559-574.
24.
Hamelahti P. , Jarvinen O., Sisto T., et al. Methylenetetrahydrofolate reductase gene C677T mutation is related to the defects in the internal elastic lamina of the artery wall. Eur J Clin Invest. 2002 ;32(12):869-873.
25.
Hultberg B. , Andersson A., Isaksson A.Higher export rate of homocysteine in a human endothelial cell line than in other human cell lines. Biochim Biophys Acta. 1998;1448(1):61-69.
26.
Bergoeing MP , Arif B., Hackmann AE, Ennis TL, Thompson RW, Curci JACigarette smoking increases aortic dilatation without affecting matrix metalloproteinase-9 and -12 expression in a modified mouse model of aneurysm formation. J Vasc Surg. 2007;45(6): 1217-1227.
27.
Golledge J. , Muller J., Daugherty A., Norman P.Abdominal aortic aneurysm pathogenesis and implications for management. Arterioscler Thromb Vasc Biol . 2006;26(12): 2605-2613.
28.
Freestone T. , Turner RJ, Higman DJ, Lever MJ, Powell JTInfluence of hypercholesterolemia and adventitial inflammation on the development of aortic aneurysm in rabbits. Arterioscler Thromb Vasc Biol. 1997;17(1):10-17.
